[go: up one dir, main page]

FI871131L - Menetelmä rokotteen valmistamiseksi - Google Patents

Menetelmä rokotteen valmistamiseksi Download PDF

Info

Publication number
FI871131L
FI871131L FI871131A FI871131A FI871131L FI 871131 L FI871131 L FI 871131L FI 871131 A FI871131 A FI 871131A FI 871131 A FI871131 A FI 871131A FI 871131 L FI871131 L FI 871131L
Authority
FI
Finland
Prior art keywords
vaccine
preparing
Prior art date
Application number
FI871131A
Other languages
English (en)
Swedish (sv)
Other versions
FI93423B (fi
FI93423C (fi
FI871131A0 (fi
Inventor
John Hugh Lyon Playfair
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868606559A external-priority patent/GB8606559D0/en
Priority claimed from GB868606560A external-priority patent/GB8606560D0/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI871131A0 publication Critical patent/FI871131A0/fi
Publication of FI871131L publication Critical patent/FI871131L/fi
Publication of FI93423B publication Critical patent/FI93423B/fi
Application granted granted Critical
Publication of FI93423C publication Critical patent/FI93423C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI871131A 1986-03-17 1987-03-16 Menetelmä rokotteen valmistamiseksi FI93423C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8606559 1986-03-17
GB868606559A GB8606559D0 (en) 1986-03-17 1986-03-17 Vaccines
GB8606560 1986-03-17
GB868606560A GB8606560D0 (en) 1986-03-17 1986-03-17 Vaccines

Publications (4)

Publication Number Publication Date
FI871131A0 FI871131A0 (fi) 1987-03-16
FI871131L true FI871131L (fi) 1987-09-18
FI93423B FI93423B (fi) 1994-12-30
FI93423C FI93423C (fi) 1995-04-10

Family

ID=26290503

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871131A FI93423C (fi) 1986-03-17 1987-03-16 Menetelmä rokotteen valmistamiseksi

Country Status (13)

Country Link
EP (1) EP0241725B1 (fi)
JP (1) JPH0832633B2 (fi)
AU (1) AU607130B2 (fi)
CA (1) CA1323302C (fi)
DE (1) DE3782960T2 (fi)
DK (1) DK175283B1 (fi)
ES (1) ES2052503T3 (fi)
FI (1) FI93423C (fi)
GR (1) GR3007080T3 (fi)
IE (1) IE59927B1 (fi)
IL (1) IL81920A (fi)
NO (1) NO871071L (fi)
NZ (1) NZ219631A (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA2090478A1 (en) * 1990-08-31 1992-03-01 Satwant K. Narula Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials
ZA936095B (en) * 1992-08-21 1994-03-14 Univ Melbourne Cytokine applications.
GB9725480D0 (en) * 1997-12-01 1998-01-28 Univ London Cytokines and their use in the treatment of established chronic infections and cancers
WO2004028561A1 (ja) * 2002-09-30 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. 免疫応答誘導方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン2を含有してなる癌治療剤
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
US4938956A (en) * 1987-04-01 1990-07-03 International Minerals & Chemical Corp. Synergistic immunostimulating composition and method

Also Published As

Publication number Publication date
NO871071D0 (no) 1987-03-16
IL81920A0 (en) 1987-10-20
FI93423B (fi) 1994-12-30
IE59927B1 (en) 1994-05-04
AU7008687A (en) 1987-09-24
ES2052503T3 (es) 1994-07-16
GR3007080T3 (fi) 1993-07-30
NZ219631A (en) 1990-03-27
JPS62277328A (ja) 1987-12-02
JPH0832633B2 (ja) 1996-03-29
FI93423C (fi) 1995-04-10
FI871131A0 (fi) 1987-03-16
CA1323302C (en) 1993-10-19
IE870684L (en) 1987-09-17
EP0241725B1 (en) 1992-12-09
AU607130B2 (en) 1991-02-28
DE3782960D1 (de) 1993-01-21
NO871071L (no) 1987-09-18
DK133287A (da) 1987-09-18
DK133287D0 (da) 1987-03-16
EP0241725A2 (en) 1987-10-21
DK175283B1 (da) 2004-08-09
EP0241725A3 (en) 1989-05-10
IL81920A (en) 1991-12-12
DE3782960T2 (de) 1993-04-29

Similar Documents

Publication Publication Date Title
FI881647L (fi) Menetelmä rasvavalmisteen valmistamiseksi
FI893929L (fi) Menetelmä stabiilin sinkki-protamiini- -interferonikompleksin valmistamiseksi
FI883783L (fi) Menetelmä nasaalivalmisteiden valmistamiseksi
FI884636L (fi) Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä
FI880163L (fi) Menetelmä lääkeaineena käytettävän liuoksen valmistamiseksi
KR880003938A (ko) 에리트로마이신 a 유도체 및 그의 제조 방법
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI873106L (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
PT87065A (pt) Process for the preparation of a vaccine against pasteurellosis
FI875295L (fi) Menetelmä hirudiinivariantin valmistamiseksi
FI871670L (fi) Menetelmä osseiini-hydroksiapatiittiyhdisteen valmistamiseksi
NO870866L (no) FremgangsmŸte for fremstilling av et terapeutisk kombinasjonspreparat.
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI873407L (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
FI870050L (fi) Menetelmä hajunpoistoaineen valmistamiseksi
ES552138A0 (es) Un procedimiento para preparar poliarilen-polieteres
FI871131L (fi) Menetelmä rokotteen valmistamiseksi
FI885045L (fi) Menetelmä polynukleotidien valmistamiseksi
FI872184L (fi) Menetelmä kationisen kopolymeerin valmistamiseksi
FI882314L (fi) Halogeeni-imidien valmistusmenetelmä
DK75487A (da) Fremgangsmaade til fremstilling af et butanonderivat
DK75087D0 (da) Fremgangsmaade til fremstilling af et butanonderivat
DK75287D0 (da) Fremgangsmaade til fremstilling af et butanonderivat
DK74987D0 (da) Fremgangsmaade til fremstilling af et butanonderivat
FI874469L (fi) Menetelmä penemien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH

MA Patent expired